US approves ‘breakthough’ gene therapy for leukaemia – South China Morning Post
South China Morning Post |
US approves ‘breakthough’ gene therapy for leukaemia
South China Morning Post The US approved the first gene therapy against cancer on Wednesday – a treatment that uses a patient’s own immune cells to fight leukaemia – opening a new era in the fight against one of the world’s top killers. The treatment is made by Novartis and is … FDA Approves Groundbreaking Gene Therapy for CancerMIT Technology Review FDA approval brings first gene therapy to the United StatesFDA.gov FDA Approves First Gene Therapy For LeukemiaNPR CNN –National Cancer Institute all 656 news articles » |
|
Editas Medicine, Inc. (NASDAQ:EDIT) Stock Closed Much Higher …
Finance Daily Company shares last traded at $21.26 significantly higher than $17.75, the stock’s 50 day moving average and well above the 200 day moving average of … |